Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07307534
Eligibility Criteria:
Inclusion Criteria:
* Patients with halo nevus accompanied by non-segmental vitiligo, with BSA ≤2% (excluding acral regions).
* Central nevus confirmed as benign melanocytic nevus through clinical observation and dermatoscope.
* Age 6 to 45 years, regardless of gender ④ Physically able to tolerate surgery and local anesthesia
Exclusion Criteria:
* History of keloid formation or hypertrophic scarring (to avoid abnormal hyperplasia at the operative site and interference with repigmentation assessment)
* Other autoimmune diseases (e.g., hyperthyroidism)
* Patients with significant endocrine disorders, psychiatric conditions, hematologic diseases, hepatic/renal disorders, cardiovascular/cerebrovascular diseases, severe infections, or other major systemic illnesses
* Use of hormonal medications, immunomodulators, or phototherapy within the past 1 month ⑤ Pregnant or lactating women ⑥ Allergy to anesthetic agents or excipients
* Poor psychological status or compliance, unable to cooperate with postoperative follow-up or care ⑧ Concurrent conditions requiring other treatments that may interfere with the study observations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
45 Years
Study:
NCT07307534
Study Brief:
Protocol Section:
NCT07307534